CDK2-IN-4

Overview

CDK2-IN-4 (compound 73) is a potent and selective CDK2 inhibitor with an IC 50 of 44 nM for CDK2/cyclin A, shows 2,000-fold selectivity over CDK1/cyclin B ( IC 50 =86 uM).

Application

Products | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK

Product Information

• Catalog No.: HY-117535
• CAS No.: 2079895-42-2
• Molecular Formula: C23H18N6O2S
• Molecular Weight: 442.49
• Purity: 99.85%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.08 mg/mL (4.70 mM); Clear solution
• Availability: In-stock

Source

Original product source